Figure 4From: Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjectsMean percent fall in FEV 1 (± SEM) during the early and late asthmatic responses. Roflumilast significantly inhibited the area of the early and late responses (p < 0.05). FEV1: forced expiratory volume in 1 second.Back to article page